Navigation Links
Nanotrope, Inc. Receives Patent on New Diagnostic Test for Influenza and Other Viral Infections

SAN DIEGO, Nov. 17, 2010 /PRNewswire/ -- Nanotrope, Inc. announced today that it has been issued United States patent #7,829,272 covering its ground-breaking diagnostic test for influenza and other viral infections. The patent describes Nanotrope's cellular mimic technology that creates an artificial "cell" engineered with specific membrane compositions and surface receptors which stimulate the virus into infecting the mimic as it would a normal host cell.  Once the cell mimic is infected, viral genome sequences are detected by multi-color fluorescence providing both viral typing and sub-typing capabilities. The sensitivity of the test is comparable to PCR (polymerase chain reaction) detection limits but in a faster, less expensive and simpler format.

The Nanotrope assay may be used to identify any envelope virus, a class of viruses that includes such important infectious disease targets as influenza where the assay can distinguish between seasonal, swine, and pandemic flu strains, RSV, a serious lung disease in young children, West Nile virus, SARS, measles, and rabies. For contagious viral infections, it is important to identify the virus early in the course of the infection so that sick patients may be isolated and properly treated. The high sensitivity, short time to result, and sub-typing capability of the new assay makes it well-suited for hospital and clinical labs where the time to diagnosis is important, as well as for global surveillance for vaccine development.

Nanotrope is a privately held nano-biomaterials company with a focus on developing new products for the pharmaceutical and diagnostic industries. Its expertise in particle technology has enabled a diverse portfolio of intellectual property. The company is actively looking for partners to commercialize its diagnostics technology. Inquiries may be directed to Dr. Donald Ackley at 858-847-7300,

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Dr. Donald E Ackley

SOURCE Nanotrope, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
2. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
3. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
4. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
5. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
6. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
7. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
8. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
9. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
10. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
11. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Post Your Comments:
(Date:11/24/2015)... Nov. 24, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: ... the company,s president and chief executive officer, will present at ... week in New York City . The ... December 1, 2015 at 9:30 a.m. EST. ... the website at least 15 minutes prior to the presentation ...
(Date:11/23/2015)... Calif., Nov. 23, 2015   Ceres, Inc . ... today financial results for the fiscal year ended August ... --> --> During ... forage and feed products with a better balance of ... signed distribution agreements with several leading crop input providers ...
(Date:11/23/2015)... PISCATAWAY, New Jersey , November 23, ... Centre (CCDC) announces the launch of the ... and the CSD-System, now complemented by three powerful ... support the discovery of new molecules, CSD-Materials for ... complete set of the CCDC,s applications incorporating CSD-Discovery ...
(Date:11/23/2015)... 2015   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... media and a related cloud hosted ... smart shippers ("BioLife" or the "Company"), today ... ), a biotechnology company focused on the discovery, ...
Breaking Biology Technology:
(Date:11/18/2015)... , Nov. 18, 2015  As new scientific ... children, doctors and other healthcare providers face challenges in ... families and patients. In addition, as more children continue ... a patient,s adulthood and old age. John ... The Children,s Hospital of Philadelphia (CHOP) . ...
(Date:11/17/2015)... 2015 Paris from 17 ... Paris from 17 th until 19 ... innovation leader, has invented the first combined scanner in the ... same scanning surface. Until now two different scanners were required: one ... capture both on the same surface. This innovation is ...
(Date:11/17/2015)...  Vigilant Solutions announces today that Mr. Dick ... --> --> Mr. ... partnership at TPG Capital, one of the largest global ... in revenue.  He founded and led TPG,s Operating Group, ... from 1997 to 2013.  In his first role, he ...
Breaking Biology News(10 mins):